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The LDHBGUA-1 variant is an electrophoretic variant which is enzymatically inactive. It is only detectable 
because of its ability to form heterotetramers with A and /o r  active B subunits and alter the electrophoretic 
pattern, although all evidence suggests the B-GUA-1 subunits are always enzymatically inactive. All 
tetrameric combinations of active plus inactive subunits including either an A or active B plus three inactive 
B subunits possess enzymatic activity. The heterotetramers composed of A and B-GUA-1 subunits are more 
thermostable than A 4 homotetramers but less thermostable than normal AB heterotetramers. The AB-GUA-1 
heterotetramers composed of active A and inactive B subunits have a K~ for pyruvate, for lactate and for 
NADH which is similar to that observed for normal AB heterotetramers. The substrate specificity of the A 
plus normal B heterotetramer and the A plus variant B heterotetramer with a-hydroxybutyrate or the 
aeetylpyridine analog of NAD as substrate are similar, while differences between the normal and variant 
erythrocyte isozymes are observed when glyoxalate is the substrate. Interaction with the B-GUA-I subunit 
reduces the sensitivity of the A subunit to urea inhibition (independent of dissociation), as does the active B 
subunit, but the inactive B subunit does not modulate the inhibition by oxalate. Although a single active 
subunit in a tetrameric conformation is sufficient for enzymatic activity, many of the kinetic properties of the 
lactate dehydrogenase molecule reflect the tetrameric structure rather than the sum of independent subunits. 
Thus communication among the subunits must exist and conformational changes which affect the catalytic 
properties of the enzyme (L-lactate:NAD ÷ oxidoreductase, EC 1.1.1.27) must occur during tetramer 
formation. 
Lactate  dehydrogenase  (L- l ac ta t e :NAD + 
oxidoreductase, EC 1.1.1.27) is a tetrameric en- 
zyme (M r ~ 140000) [1,2] catalyzing the intercon- 
version of L-lactate and pyruvate via an ordered 
mechanism which requires the initial binding of 
the pyridine nucleotide [3-6]. The lactate dehydro- 
genase subunits are the products of two loci-M or 
A (muscle) and H or B (heart) and five different 
Abbreviation: Hepes, N-  2 - hydroxyethylpiperazine- N '  - 2-  
ethanesulfonic acid. 
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tetramers, separable by electrophoresis are ob- 
served in various tissues [2,7]. The relative pre- 
ponderance of each isozyme is tissue specific within 
species [8,9] and reflects the relative rates of 
synthesis and degradation of the subunits in each 
tissue [1O,11]. 
Extensive sequence and conformation data have 
been accumulated on the B and A forms of lactate 
dehydrogenase from many species. Only small dif- 
ferences in tertiary structure are observed, al- 
though significant differences in amino acid se- 
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quence between species and isozymes are noted 
[12,13]. Differences in tertiary structure between 
the apo-lactate dehydrogenase enzyme and the 
substrate-cofactor-enzyme complex do exist 
[12,14], and conformational changes of the later 
may be associated with the differences in kinetic 
properties between the heart and muscle isozymes 
[151. 
The catalytic and stability properties of the 
lactate dehydrogenase tetramer reflect their sub- 
unit composition. The B 4 isozyme from mammals 
has a higher affinity for substrate than the A 4 
isozyme [1] and approximately half the turnover 
number [16]. The B 4 isozyme is also more sensitive 
to structural modifications at the C 3 position of 
the pyridine nucleotide cofactor [17,18] and to 
pyruvate inhibition [1]. The B 4 isozyme is relatively 
insensitive to changes in chain length of the a keto 
acid, retaining almost 80% of normal activity when 
pyruvate is replaced by a-ketobutyrate [18] or 
glyoxalate [19] as substrate. The B 4 isozyme is 
more resistant to inhibition by 2 M urea than the 
A 4 isozyme [20] but is more sensitive to oxalate 
inhibition [21,22]. These differences in catalytic 
properties have stimulated much discussion re- 
garding the significance of the tissue specificity of 
the lactate dehydrogenase isozyme profile [23]. 
The characteristics of the hybrid tetramer are a 
property of the subunit composition, with the A 2 B2 
heterotetramer having properties intermediate to 
the A 4 and B 4 isozymes [2]. These differences in 
characteristics have been utilized to determine the 
total A to B subunit ratio in various tissues and 
samples [24]. It has been shown that individual 
subunits are not enzymetically active [25], but only 
limited studies have been conducted regarding the 
nature and the role of subunit interactions in 
determining the catalytic and stability properties 
of this enzyme [26,27]. 
The LDHBGUA-1 variant, previously identified 
as a genetic polymorphism among the Guaymi 
Indians of Panama and Costa Rica, is char- 
acterized by an altered electrophoretic mobility for 
lactate dehydrogenase-2, 3 and 4, while no en- 
zymatic activity is detectable in the lactate dehy- 
drogenase-1 (B4) region of the gel [28,29]. Char- 
acterization of this variant, which is without en- 
zymatic activity, has provided us with a unique 
opportunity to study the subunit interactions oc- 
curring in the heterotetrameric molecule of lactate 
dehydrogenase, independently of the enzymatic 
activity of the B subunit. 
Materials and Methods 
Blood samples were collected from the Guaymi 
Indians in Costa Rica into acid-citrate-dextrose 
anticoagulent vacutainers and shipped at 4°C to 
Ann Arbor [29]. The plasma was removed and the 
cells repeatedly washed with saline; packed red 
blood cells and plasma were stored in liquid 
nitrogen. Human liver samples, obtained at time 
of autopsy, were washed and stored in liquid 
nitrogen. 
Electrophoresis was performed using a 7% poly- 
acrylamide slab gel in a continuous Tris-glycine 
buffer system (37 mM Tris/0.182 M glycine, pH 
8.5) [30] or the discontinuous system of Davis [31]. 
Lactate dehydrogenase isozyme bands were visual- 
ized as described previously [30]. 
Red blood cell and liver samples for thermosta- 
bility, relative enzyme activity and substrate ana- 
log studies were prepared as follows: packed red 
blood cells were diluted 1:6 (v/v) with lysing 
buffer (10 mM Hepes, 1 mM EDTA, 1 mM di- 
thiothreitol, 0.06% Triton X-100, pH 7.0) and 
centrifuged at 48000 × g for 20 min at 4°C. Liver 
samples were thawed, weighed and suspended in 
50 mM Tris-HC1 buffer, pH 7.5 (1:10, w/v). 
Soluble proteins were extracted by homogeniza- 
tion with a Bfinkmann Polytron. The homogenates 
were centrifuged at 48000 × g for 30 min at 4°C. 
The supernatant fractions from hemolysates and 
liver homogenates were used as described in the 
text. 
Enzymatic activity was determined on a centri- 
fugal analyzer interfaced with a PDP-8e computer 
[32]. Units of enzyme activity (IU) are #tool prod- 
uct formed per min at 30°C. All chemicals were of 
reagent grade and used without further purifica- 
tion with the exception of 3-acetylpyridine adenine 
dinucleotide (Sigma Chem. Co., St. Louis, MO) 
which was re-chromatographed on a DEAE-52 
ion-exchange column developed with a 0-3% NaCI 
gradient. 
Michaelis constants were determined utilizing 
the unweighted nonlinear regression method of 
Wilkinson [33] and the computer program de- 
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Fig. I. Purification of lactate hydrogenase. 5 ml of liver homo- 
genate containing approx. 400 IU of lactate dehydrogenase 
activity in buffer A (20 mM NaHPO 4 (pH 7.0), 0.5 M NaCI 
and 400/~M NADH) was applied to the column. Washing with 
buffer A was continued until the A280 of the eluant was less 
than 0.005. Lactate dehydrogenase was then eluted with buffer 
B (20 mM NaHPO 4 (pH 7.0), 1 mM pyruvate). 
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Fig, 2. Electrophoretic pattern of normal and variant lactate 
dehydrogenase. (a) Electrophoresis of lactate dehydrogenase 
from plasma from a normal (well 4), a heterozygous (wells 1 
and 3) and a homozygous (well 2) individual was conducted as 
described in Materials and Methods utilizing a continuous 
buffer system. O is the origin. The bands were visualized by 
staining for enzyme activity. (b) Electropboresis of plasma from 
a heterozygous variant individual as described in Materials and 
Methods as the Davis method. The bands were visualized by 
staining for enzyme activity. 
scribed by Tiffany et al. [34] with purified lactate 
dehydrogenase samples from red blood cells and 
liver. Protein concentration was determined as de- 
scribed by Sedmak and Grossberg [35] and also by 
the A280 extinction coefficient [36]. 
The enzyme was purified utilizing a modifica- 
tion of the oxamate affinity chromatographic tech- 
nique [37]. (Oxalic acid was bound to ~0- 
aminohexyl-Sepharose from Sigma Chem. Co., St. 
Louis, MO). A column 0.8 × 3 cm was used, which 
was of sufficient size to bind 275 IU of lactate 
dehydrogenase. After loading the sample, either 
liver homogenate or red cell hemolysate, and ex- 
tensive washing to remove unbound protein, the 
lactate dehydrogenase was eluted in the presence 
of 1 mM pyruvate (Fig. 1). The inclusion of pyru- 
vate in the elution buffer sharpened the peak of 
lactate dehydrogenase activity considerably. Puri- 
fied lactate dehydrogenase fractions were judged 
homogeneous by the presence of only two protein 
bands corresponding to dissociated lactate dehy- 
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Fig. 3. Schematic diagram of electrophoretic pattern from Fig. 
2a and 2b. B ° designates the inactive B-GUA subunit and 
--indicates the expected position of the B 4 tetramer. 
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drogenase A and B -[ 11 ] subunits after Coomassie 
blue staining of samples electrophoresed on sodium 
dodecyl sulfate (SDS) polyacrylamide gels [38]. 
Results 
Electrophoretic analysis 
The electrophoretic pattern of lactate dehydro- 
genase from presumptive heterozygous (normal + 
variant) and homozygous variant individuals is 
shown in Fig. 2. The A 4 (M 4 or lactate dehydro- 
genase-5) band migrates cathodally in this poly- 
acrylamide gel electrophoresis buffer system but is 
observed as a single band on starch gel electro- 
phoresis [28]. The band patterns corresponding to 
the A3B 1, A2B 2 and A~B 3 tetramers in both het- 
erozygous and homozygous variant individuals are 
consistent with the existence of an electrophoretic 
variant of the B locus of lactate dehydrogenase 
(Fig. 2a). The absence of a band corresponding to 
the B 4 tetramer in the homozygous individual and, 
in this same region of the gel, a four-banded rather 
than the expected five-banded pattern in the het- 
erozygous individual, again without the B 4 band 
(Fig. 2b), suggested that the variant subunit re- 
sponsible for the altered electrophoretic pattern 
was enzymatically inactive, at least in a tetramer 
composed of four variant subunits. A similar alter- 
ation in electrophoretic pattern, again with the B 4 
band missing, was observed when erythrocytes 
rather than plasma were the source of enzyme. The 
decreased staining intensity of the various bands 
containing 1-3 variant B subunits suggested that 
the B-GUA-1 subunit was not only inactive when 
combined with itself but was probably inactive 
when combined with normal A or B subunits. A 
schematic representation of the electrophoretic 
pattern (activity stain) is found in Fig. 3. 
Enzyme activity 
The level of total enzyme activity in both 
erythrocytes and plasma is consistent with the 
interpretation that the B-GUA-1 subunit is en- 
zymatically inactive (Table I). The 22% of expected 
activity in erythrocytes from homozygous variant 
individuals agrees well with the estimation that 
20% of the lactate dehydrogenase subunits in 
erythrocytes are products of the A locus [9]. It is 
estimated that approximately 30% of the lactate 
TABLE I 
T H E  LEVEL OF LACTATE D E H Y D R O G E N A S E  ACTIV- 
ITY IN ERYTHROCYTES A N D  PLASMA F R O M  NOR- 
MAL A N D  VARIANT INDIVIDUALS 
Assays were as described in Materials and Methods. N equals 6 
in each group for erythrocytes and 5 for plasma. , 
Erythrocytes Plasma 
( I .U . /g  H g b ±  S.D.) ( I .U . /ml  ± S.D) 
Normal  172 ± 10.6 0.25 ± 0.007 
Heterozygous 
variant 85 ± 7.8 (50%) a 0.20---0.03 (80%) 
Homozygous 38 ± 9.6 (22%) 0.09 ± 0.02 (36%) 
a % of normal 
dehydrogenase subunits in plasma are of the A 
type, consistent with the 36% of normal activity in 
plasma from homozygous variant individuals. The 
level of enzyme activity in plasma and erythro- 
cytes from heterozygous individuals is as expected 
if all of the A and 50% of the B subunits are 
active. The specific activity of the lactate dehydro- 
genase purified from erythrocytes from a homo- 
zygous variant individual was 66 IU/mg, c o m -  
pared to a specific activity of 272 IU/mg for 
lactate dehydrogenase from normal erythrocytes, 
which is similar to previous reports for lactate 
dehydrogenase B [36]. Approximately 60 IU/mg is 
the specific activity expected if the lactate dehy- 
drogenase B-GUA-1 subunits were present in nor- 
mal quantity but were enzymatically inactive. 
Thermostability 
The thermostability of the lactate dehydro- 
genase from erythrocytes of homozygous and het- 
erozygous variant individuals was compared to 
lactate dehydrogenase with a normal electro- 
phoretic pattern from erythrocytes (composed of 
80% B subunits) or liver (composed of 80% A 
subunits) (Fig. 4). As has been previously reported, 
the A subunits are less resistant to thermode- 
naturation than are B subunits [39]. The thermode- 
naturation profile of lactate dehydrogenase from 
erythrocytes of a homozygous variant individual is 
intermediate tO the stability of lactate dehydro- 
genase from normal erythrocytes and liver indicat- 
ing that the enzymatically inactive B-GUA-1 sub- 
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Fig. 4. Thermostability profile of erythrocyte lactate dehydro- 
genase from normal and variant individuals. Aliquots were 
incubated at 61°C for the indicated time, transferred to a 4°C 
bath and centrifuged at 4 8 0 0 0 × g  to remove precipitated pro- 
tein. Assays were conducted as described in Materials and 
Methods and the activity remaining was expressed as a percent 
of the original activity. Samples are (0 )  normal erythrocyte, 
( o ) heterozygous variant erythrocyte, ( 1 )  homozygous variant 
erythrocyte and (/x) normal liver. 
units confer some thermostability to the A sub- 
units. The rate of loss of enzyme activity of the 
homozygous variant should have been more rapid 
relative to that observed for lactate dehydrogenase 
from liver, which has 20% B subunits, if the rate of 
thermodenaturation were only a property of the 
active subunits. 
Kinetic properties 
The kinetic properties of the lactate dehydro- 
genase A 4 and B 4 tetramers are very different, thus 
the kinetic properties of lactate dehydrogenase 
from four sources (liver (80% A subunits), 
erythrocytes from a normal individual (80% B 
subunits), erythrocytes from a heterozygous variant 
individual (20% A, 40% B, 40% inactive B) and 
erythrocytes from a homozygous variant individ- 
ual (20% A, 80% inactive B) were determined 
(Table II). THe K~ values for pyruvate for lactate 
dehydrogenase from liver and normal erythrocytes 
were 3 .6 .10-4M and 1.4.10-4M, respectively, 
consistent with previous reports for the mam- 
malian A 4 isozymes [1] and the human B 4 isozyme 
[36]. The K m for pyruvate for erythrocyte lactate 
dehydrogenase from the homozygous variant indi- 
vidual (all activity due to the A subunits) was 
1.0.10-4M and similar to normal erythryocyte 
lactate dehydrogenase, which is composed of 80% 
B subunits. The K m value obtained for the lactate 
dehydrogenase from the heterozygous variant indi- 
vidual (1.3.10-4M) was also nearly identical to 
the value obtained for the normal erythrocyte en- 
zyme. Similarly, the enzyme from normal, hetero- 
zygous variant and homozygous variant red cells 
each had similar K~ values for lactate and NADH 
((0.5-0.8)- 10-2 M and (1.2-2.3). 10-5 M, respec- 
tively) and thus different from the 2.2.10-2 and 
TABLE II 
MICHAELIS CONSTANTS FOR LACTATE D E H Y D R O G E N A S E  TETRAMERS COMPOSED OF A PLUS N O R M A L  
A N D / O R  VARIANT B SUBUNITS 
All assays are described in Materials and Methods. 
K m ( i )  
Liver Heterozygous Homozygous Normal 
variant variant Erythrocyte 
Pyruvate 3.6-10 -4  1.3.10 -4  1.0.10 -4  1.4- 10 -4  
Lactate 2.2- 10 -2  0.8.10 -2  0.5.10 -2  0.7.10 -2  
N A D H  16 . 1 0 - 5  2 .3 .10 -5  1 .8 .10-5  1.2-10-5 
1 6 . 1 0 - 5  M values obtained with the liver enzyme. 
The standard deviation for the K m determinations 
is approx. 8-14% of the K m value, thus the Kmval- 
ues for the different substrates obtained with 
lactate dehydrogenase from liver and normal 
erythrocytes differ by some 30-times the standard 
deviation. 
Substrate specificity 
The heart (B) type and muscle (A) type en- 
zymes exhibit quantitative differences in substrate 
specificity with the heart type enzyme, having 
higher activity with a hydroxybutyrate and 
glyoxylate as substrate. The erythrocyte lactate 
dehydrogenase, 80% B type, has 83% of normal 
activity with a-hydroxybutyrate as substrate while 
the liver sample (20% B) has only 34% of the 
activity obtained with pyruvate as substrate (Table 
III). The enzyme from erythrocytes of homozygous 
and heterozygous variant individuals retains 90 
and 75% of the activity with the alternate substrate 
relative to the normal assay with 0.7 mM pyruvate 
as substrate. Glyoxylate is also an alternative sub- 
strate, but with a chain length one carbon shorter 
than pyruvate. In contrast to the results with the 
higher carbon chain homolog, the activity, with 
glyoxalate as substrate relative to pyruvate, of the 
homozygous variant is 0.23 and similar to the ratio 
observed for the liver enzyme (0.24). Thus the 
glyoxalate activity reflects the ratio of active sub- 
units in the heterotetramer. Specific differences in 
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substrate specificity between the A and B enzyme 
are also noted when the acetylpyridine analog of 
N A D  replaces NAD in the enzyme reaction with 
the B type enzyme being more sensitive to the 
substitution of structural analogs. As observed in 
Table III, the erythrocyte lactate dehydrogenase 
retained less activity than did the liver enzyme 
when NAD was replaced by 3-acetylpyridine 
adenine dinucleotide. The heterotetramers from 
the homozygous variant individuals retained essen- 
tially the same activity as the normal erythrocyte 
enzyme, thus the response reflected the ratio of A 
to total B type subunits present in the sample. 
Inhibitor studies 
Urea inhibits the enzyme reaction via a mecha- 
nism involving conformational alterations of the 
NAD binding sites [22]. The A type enzyme is 
more sensitive to inhibition, with only 15% of the 
activity remaining after 20 rain, than is the B type 
enzyme which retains 70% of the initial activity. 
The lactate dehydrogenase of erythrocytes from 
heterozygous and homozygous variant individuals 
has the same sensitivity to inhibition (68% and 
72% remaining) as the erythrocyte enzyme from 
normal individuals (Table IV). 
Oxalate is a non-competitive inhibitor of lactate 
dehydrogenase (assayed in the direction of pyru- 
vate to lactate) with the B type enzyme being more 
sensitive than the A type enzyme [18]. The liver 
enzyme, assayed in the presence of 0.1 mM oxalate, 
TABLE III 
SUBSTRATE SPECIFICITY OF LACTATE DEHYDROGENASE TETRAMERS COMPOSED OF A PLUS NORMAL AND/OR 
VARIANT B SUBUNITS 
All assays are described in Materials and Methods 
Relative activity 
L i v e r  H e t e r o z y g o u s  Homozygous Normal 
variant variant Erythrocyte 
a-Hydroxybutyrate/pyruvate a 0.34 0.75 0.90 0.83 
Glyoxalate/pyruvate b 0.24 0.31 0.23 0.40 
AC Pyr NAD/NAD c 0.57 0.25 0.29 0.22 
a Activity with 0.7 mM a-hydroxybutyrate as substrate divided by activity with 0.3 mM pyruvate as substrate. 
b Activity with 0.7 mM glyoxalate as substrate divided by activity with 0.3 mM pyruvate as substrate. 
c Activity with 1.5 mM acetylpyridine NAD as substrate divided by activity with 1 mM NAD as substrate, 
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TABLE IV 
INHIBITOR STUDIES OF LACTATE DEHYDROGENASE TETRAMERS COMPOSED OF A PLUS NORMAL AND/OR 
VARIANT B SUBUNITS 
All assays are described in Materials and Methods 
Relative activity 
Liver Heterozygous Homozygous Normal 
variant variant Erythrocyte 
Urea inhibition a 15 68 72 70 
Oxalate inhibition b 37 30 41 20 
a Activity remaining after 20-min preincubation in presence of 2 M urea and 0.3 mM NADH × 100. 
b Activity in presence of 0.1 mM oxalate and 0.7 mM pyruvate divided by activity without oxalate × 100. 
retains 27% of the activity measured in the pres- 
ence of 0.7 mM pyruvate but without oxalate. The 
normal erythrocyte enzyme retains only 20% activ- 
ity when assayed under the same set of conditions. 
The erythrocyte lactate dehydrogenase from the 
heterozygous individual retains 30% of normal ac- 
tivity and the enzyme from the homozygous variant 
individual retains 41% of normal activity (Table 
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Fig. 5. Summary of kinetic properties of lactate dehydrogenase 
isozymes. The samples are (I-q) normal erythrocyte, (©) hetero- 
zygous variant erythrocyte, (A) homozygous variant erythro- 
cyte and (×)  normal liver. The values obtained when lactate 
dehydrogenase from normal erythrocytes and liver were studied 
were assigned positions at 80% and 20% B like characteristics, 
respectively. The positions for the heterozygous and homo- 
zygous variants were calculated from the data presented in 
Tables II-IV. 
IV). The response to oxalate addition to the en- 
zyme reaction reflects the ratio of active B to 
active A subunits rather than the total B to A ratio 
as observed for other kinetic properties. 
As seen in Fig. 5, for four of six kinetic proper- 
ties which are useful for discriminating between 
lactate dehydrogenase A and B, the characteristics 
of the mixed tetramers are not dependent upon the 
B subunit's being enzymatically active. However, 
for two other characteristics, subunit interactions 
do not appear to alter the conformation of the 
active sites sufficiently to make all of the subunits 
catalytically similar. 
Discussion 
The LDHBGUA-1 variant appears to be a 
classic example of a catalytically inactive, CRM + 
variant. The altered electrophoretic pattern of en- 
zyme from erythrocytes and plasma is consistent 
with the presence of a variant at the B locus of 
lactate dehydrogenase, except that the B-variant 
homotetramer is not detectable with enzyme- 
specific staining. The level of enzymatic activity in 
erythrocytes and plasma from homo- and hetero- 
zygous individuals and the reduced specific activ- 
ity of the enzyme purified from erythrocytes and 
plasma of affected individuals suggests that the 
B-GUA-1 subunit is enzymatically inactive even 
when combined with normal A or B subunits. 
Previous studies with enzyme bound to inert 
resins indicated that the individual subunits of 
lactate dehydrogenase are not enzymatically active 
[25]. The existence of bands corresponding to A 1 
B-GUA-13 and B I B-GUA-13 tetramers, although 
not in conflict with the previous observation that 
subunits are catalytically inactive [25], indicates 
that a single active subunit in combination with 
three inactive subunits has catalytic function. This 
would suggest that the conformational changes 
which occur during tetramer formation are critical 
to the realization of catalytic function for this 
enzyme. Additional evidence for this interaction is 
obtained from examining other properties of the 
heterotetramers. The inactive B subunits appear to 
confer quite normal conformational changes on 
the active A subunit in that the A subunits in 
combination with from one to three B-GUA-1 
subunits have K m values for pyruvate, lactate and 
N A D H  which are not different from K m values 
determined for molecules consisting of A plus 
active B subunits. These K m values are different 
from the values observed for the A 4 tetramer. 
Similarly, the inactive B subunits influence the 
substrate specificity of the heterotetramer in terms 
of activity toward a hydroxybutyrate and acetyl- 
pyridine NAD in a manner almost identical to 
that of the active B subunits. Also the response of 
the heterotetramer to structural alterations due to 
urea incubation in the presence of NADH was not 
affected by the replacement of active B by inactive 
B subunits. Thus each of these kinetic characteris- 
tics reflects the total A to B ratio rather than the 
ratio of A to active B subunits. This is not in 
conflict with previous observations that the hybrid 
tetramers have intermediate properties [2], but does 
suggest that interactions between nonidentical 
subunits are instrumental in determining these 
properties. More important, these results suggest 
that each subunit in the tetramer has similar char- 
acteristics and that the kinetic characteristics of 
the tetramer are not simply the numerical average 
of subunits with different properties. At least four 
properties of the enzyme reflect the interaction of 
subunits with differing characteristics and are in- 
dependent of the catalytic function of the subunit. 
Two kinetic parameters, the activity with the 
2-carbon substrate analog, glyoxalate, and the re- 
sponse to assaying the enzyme in the presence of 
oxalate, were different between AB and A B  GUA-I 
heterotetramers and reflect the A to active B ratio 
rather than A to total B ratio. It is not yet clear if 
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this difference is related to the structural alteration 
causing the B-GUA-1 molecule to be inactive or 
indicates that conformation changes associated 
with tetramer formation have a lesser effect on 
glyoxalate and oxalate binding. 
Many examples of subunit interaction associ- 
ated with regulatory subunits [40], ordering of 
substrate binding [41] or binding of regulatory 
molecules [42] are known. Most of the interactions 
involving identical subunits act to make the cata- 
lytic sites nonequivalent, which appears to be the 
converse of the situation with the lactate dehydro- 
genase molecule; that is, interaction between non- 
identical subunits alters the active site of each 
subunit in a manner which apparently makes all 
four sites catalytically similar. These data suggest 
that the conformational changes which occur upon 
tetramer formation are responsible for determin- 
ing many of the kinetic properties of the lactate 
dehydrogenase molecule and that within the het- 
erotetramic molecule a high level of communica- 
tion exists between subunits. 
The lactate dehydrogenase B-GUA-1 variant is 
found among the Guaymi Indians of Panama [28] 
and Costa Pica [29], occurring with an allele 
frequency of approximately 0.10. Some 10 individ- 
uals have been identified as being homozygous- 
deficient. This group includes several mature 
adults, thus the enzyme deficiency would not ap- 
pear to be associated with severe negative meta- 
bolic consequences, which would be selected 
against in this primitive population. In addition to 
the erythrocyte, this enzyme deficiency should be 
most severe in heart tissue where the B subunit is 
responsible for approximately 80% of the en- 
zymatic activity [9]. K_itamura et al. [43] have 
described a hereditary deficiency of lactate dehy- 
drogenase, also associated with the B-locus. No 
indication of the presence of any B type subunit 
was observed during studies of this variant. The 
lactate dehydrogenase deficiency in this individual 
was associated with impaired glucose tolerance 
and a slightly elevated serum cholesterol and the 
individual was a marginal diabetic. Similar studies 
have not been conducted among the Guaymi Indi- 
ans. Significant metabolic consequences might not 
be observed in the Guaymi, because the residual 
enzyme activity has nearly normal kinetic proper- 
ties. It is still of interest that this enzyme de- 
98 
ficiency and a low activity variant of erythrocyte 
acid phosphatase have both attained high frequen- 
cies in this tribe [28,29]. 
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